Viyash Scientific Reschedules Q3FY26 Earnings Call to Feb 06
Viyash Scientific Limited has rescheduled its Q3FY26 earnings conference call to Friday, February 06, 2026, at 5:30 PM IST. The call will feature the Managing Director & Group CEO, CEO of Animal Health, and CFO.
Rescheduling a conference call, without any change in the financial results or business outlook, has a minimal impact on the company's stock.
The announcement is a rescheduling of a previously planned conference call and does not contain new financial information or material business updates that would indicate a positive or negative sentiment.
Viyash Scientific Limited (formerly Sequent Scientific Limited) has rescheduled its conference call to discuss the Company's Q3FY26 financial results. The call, originally intimated on January 21, 2026, will now take place on Friday, February 06, 2026, at 5:30 p.m. IST.
The conference call will feature the senior management, including Dr. Hari Babu Bodepudi, Managing Director & Group CEO; Mr. Rajaram Narayanan, Executive Director and CEO – Animal Health; and Mr. Ramakant Singani, Chief Financial Officer. The call details, including dial-in numbers and registration links, are available on the Company's website under the Investors section.
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.